SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
1-Year Return
18.59%
This Quarter Return
+19.44%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.38B
AUM Growth
+$6.07M
(+0.26%)
Cap. Flow
-$155M
Cap. Flow
% of AUM
-6.52%
Top 10 Holdings %
Top 10 Hldgs %
39.28%
Holding
113
New
41
Increased
19
Reduced
15
Closed
24
Top Buys
| 1 |
Nike
NKE
|
$58.3M |
| 2 |
Wynn Resorts
WYNN
|
$56.5M |
| 3 |
AT&T
T
|
$54.3M |
| 4 |
Biohaven
BHVN
|
$52.5M |
| 5 |
Colgate-Palmolive
CL
|
$50.8M |
Top Sells
| 1 |
Microsoft
MSFT
|
$89.1M |
| 2 |
Walt Disney
DIS
|
$87.4M |
| 3 |
Amazon
AMZN
|
$82.9M |
| 4 |
IQVIA
IQV
|
$72.7M |
| 5 |
Global Payments
GPN
|
$71.2M |
Sector Composition
| 1 | Healthcare | 46.26% |
| 2 | Consumer Discretionary | 16.29% |
| 3 | Industrials | 12.13% |
| 4 | Consumer Staples | 8.08% |
| 5 | Technology | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ultragenyx Pharmaceutical
RARE
$3.01B
| $37.9M | 1.59% |
817,171
+728,231
| +819% | +$33.7M |
|
|
KDNY
27
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $37.9M | 1.59% |
1,444,830
+54,830
| +4% | +$1.44M |
|
28
Constellation Energy
CEG
$96.6B
| $37.2M | 1.56% |
+431,969
| New | +$37.2M |
|
29
Terns Pharmaceuticals
TERN
$618M
| $35.1M | 1.47% |
+3,448,275
| New | +$35.1M |
|
30
Advanced Micro Devices
AMD
$263B
| $31.3M | 1.32% |
+483,756
| New | +$31.3M |
|
31
Fulcrum Therapeutics
FULC
$372M
| $31.1M | 1.31% |
4,274,803
+746,803
| +21% | +$5.44M |
|
32
Energy Select Sector SPDR Fund
XLE
$27.2B
| $30M | 1.26% |
+342,570
| New | +$30M |
|
33
Meta Platforms (Facebook)
META
$1.88T
| $29.6M | 1.24% |
246,259
-252,031
| -51% | -$30.3M |
|
34
Oracle
ORCL
$626B
| $29.3M | 1.23% |
+358,313
| New | +$29.3M |
|
35
Kezar Life Sciences
KZR
$28M
| $24.7M | 1.04% |
350,426
+22,874
| +7% | +$1.61M |
|
36
GFL Environmental
GFL
$17.5B
| $22M | 0.93% |
753,818
| – | – |
|
37
ProKidney
PROK
$310M
| $21.9M | 0.92% |
3,193,175
| – | – |
|
38
McKesson
MCK
$86B
| $21.8M | 0.92% |
58,108
-46,742
| -45% | -$17.5M |
|
39
Cogent Biosciences
COGT
$1.81B
| $20.9M | 0.88% |
1,811,396
-51,204
| -3% | -$592K |
|
40
Cencora
COR
$56.7B
| $20.7M | 0.87% |
124,658
-217,121
| -64% | -$36M |
|
41
Agios Pharmaceuticals
AGIO
$2.1B
| $19.3M | 0.81% |
685,772
-273,442
| -29% | -$7.68M |
|
|
MRNS
42
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $19.2M | 0.81% |
4,822,995
+1,285,295
| +36% | +$5.12M |
|
|
PNT
43
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $19.2M | 0.8% |
2,627,000
+296,098
| +13% | +$2.16M |
|
|
DFS
44
DELISTED
Discover Financial Services
DFS
| $16.3M | 0.69% |
+166,809
| New | +$16.3M |
|
45
Elevance Health
ELV
$69.4B
| $14.9M | 0.62% |
+28,971
| New | +$14.9M |
|
46
NVIDIA
NVDA
$4.18T
| $12.8M | 0.54% |
+873,580
| New | +$12.8M |
|
47
Prothena Corp
PRTA
$442M
| $12.4M | 0.52% |
206,448
-110,083
| -35% | -$6.63M |
|
48
Ross Stores
ROST
$50B
| $12.2M | 0.51% |
+105,040
| New | +$12.2M |
|
49
EyePoint Pharmaceuticals
EYPT
$819M
| $11.7M | 0.49% |
3,347,897
+114,300
| +4% | +$400K |
|
50
Oric Pharmaceuticals
ORIC
$1.05B
| $11.2M | 0.47% |
1,902,643
| – | – |
|